FDA Adverse Event Injury Summary report: N

CAPSUREFIX NOVUS

MDR report key: 1991562 · Received February 15, 2011

Report

Report Number
2649622-2011-02438
Event Type
Injury
Date Received
February 15, 2011
Date of Event
December 1, 2010
Manufacturer
MEDTRONIC PUERTO RICO, INC.
Product Code
DTB
PMA / PMN Number
P930039/S009
Removal / Correction Number
ASKU
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE VENTRICULAR CAPTURE MANAGEMENT (VCM) FEATURE WAS DETECTING HIGHER THRESHOLDS THAN THOSE FOUND VIA THE IN-CLINIC TESTING, AND IT WAS NOTED THAT AN IN-CLINIC VCM TEST SHOWED PRE-VENTRICULAR CONTRACTION ECTOPY OCCASIONALLY BEING ERRONEOUSLY LABELED AS LOSS OF CAPTURE. IT WAS ALSO REPORTED THAT THE ATRIAL LEAD EXPERIENCED SMALL ATRIAL FIBRILLATION WAVES. IN ADDITION, THE PATIENT COMPLAINED OF COUGHING, WITH ABDOMINAL HEAVING. THE PATIENT FURTHER REPORTED THAT AFTER THE PHYSICIAN "MADE AN ADJUSTMENT" TO THE DEVICE, THERE ARE NOW "EPISODES" WHERE THE PATIENT CAN NOT BREATHE, WHICH LAST ABOUT 30 SECONDS, AND FEEL AS IF THE DIAPHRAGM IS BEING STIMULATED. THE DEVICE REMAINS IN USE. THE VCM FEATURE WAS REPROGRAMMED, AND THE VENTRICULAR LEAD REMAINS IN USE. THE ATRIAL LEAD SENSITIVITY WAS REPROGRAMMED, AND THE ATRIAL LEAD REMAINS IN USE NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CAPSUREFIX NOVUS IMPLANTABLE PACING LEAD DTB MEDTRONIC PUERTO RICO, INC. 5076 ASKU

Patients

Seq Age Sex Outcome Treatment
1 98 YR Life Threatening| R